-
Document de presse | 2020.03.19
CEPI collaborates with the Institut Pasteur in a consortium to develop Covid-19 vaccine
Consortium to be led by the Institut Pasteur and will include Themis and the University of Pittsburgh.CEPI to provide initial US$4.9 million for consortium to develop a Covid-19 vaccine candidate based on measles-vector technology.Partnership becomes eighth Covid-19 vaccine development project that CEPI has signed since Jan 23, 2020 OSLO, NORWAY, March 19, 2020 – CEPI, the Coalition for...
-
Document de presse | 2020.03.20
Editorial: Facing challenges with the novel coronavirus SARS-CoV-2 outbreak
On December 31, 2019, Chinese authorities reported a cluster of pneumonia cases in Wuhan, China, most of which included patients whoreported exposure to a seafood market selling live animals. Emergence of a new pathogenic zoonotic coronavirus (SARS-CoV-2) was suspected. How can we face the challenges with the novel coronavirus SARS-CoV-2 outbreak?Read the editorial of Pr Sylvie van der Werf and...
-
Page avancée | 2020.03.27
Coronavirus SARS-CoV-2 : the Institut Pasteur mobilization
Coronavirus SARS-CoV-2 : the Institut Pasteur mobilization
-
Article | 2020.03.27
Coronavirus (Covid-19) research projects
VACCINE CANDIDATES1. Development of an animal model and accelerated development of a DNA vaccine candidate(SCARD SARS-CoV-2 project)Aims:To develop a mouse model of SARS-CoV-2 infection.This will not only enable us to evaluate the efficacy of the vaccine; it will also facilitate in vivo research on SARS-CoV-2. To evaluate the immunogenicity (ability to induce a specific immune reaction) and...
-
Document de presse | 2020.03.12
Covid-19: 20 research projects selected to fight the epidemic
At a time when the Sars-CoV-2 epidemic is continuing to spread, France is mobilizing to accelerate research into the virus and Covid-19 disease through REACTing – a consortium coordinated by Inserm. With the support of the Ministry of Solidarity and Health and the Ministry of Higher Education, Research and Innovation, the Scientific Advisory Board of REACTing has selected 20 scientific...
-
Report | 2020.04.03
Coronavirus SARS-CoV-2: A look back at three months of mobilisation against an emerging disease (COVID-19)
On December 31, 2019, the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. It was the official beginning of an epidemic that would rapidly become worldwide. In January, a task force was put in place at the Institut Pasteur and research projects were quickly launched. Here is a look back at three...
-
News | 2020.04.15
MOOC Advances in Stem Cell Biology
2ND EDITION OF THE FREE ONLINE COURSE OF THE INSTITUT PASTEURRealized with the support of the Fondation Ipsen, under the aegis of Fondation de FranceStem cells have the spectacular ability to restore the function of damaged tissues, providing major opportunities for fundamental studies on organogenesis, regeneration, diseases, and ageing. In spite of intense research in this field, many...
-
News | 2020.03.18
Pasteur's Nephew – Or the Adventurous Life of Adrien Loir, Scholar and Globe-Trotter
What would you say if, during this period of confinement, you had the opportunity to meet up (virtually) with Louis Pasteur and his nephew Adrien Loir? Why not make the most of this unique time to catch up on some reading and find out more about Louis Pasteur and his family? There are plenty of bookshops available online! Pasteur's Nephew – Or the Adventurous Life of Adrien Loir, Scholar and...
-
News | 2020.04.16
MOOC Vaccinology
NEW EDITION OF THE FREE ON-LINE COURSE OF INSTITUT PASTEUR Realized with the support of the Fondation Ipsen, under the aegis of Fondation de France.Vaccines are among the most effective public health interventions currently available. Several diseases have been eradicated or reduced drastically through vaccination. Together, with antibiotics and clean water, vaccines have increased life...
-
Document de presse | 2020.04.16
Bill & Melinda Gates Medical Research Institute and the Institut Pasteur to Develop a Novel Vaccine Against Shigella
The Bill & Melinda Gates Medical Research Institute (Gates MRI) and the Institut Pasteur have entered into an exclusive collaboration and license agreement to jointly develop a quadrivalent synthetic carbohydrate-based conjugate vaccine against Shigella flexneri serotypes 2a, 3a, and 6 and Shigella sonnei. Gates MRI will have an exclusive license for manufacture and commercialization of...
